Sarepta Therapeutics (SRPT) Net Margin (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,151.00 |
| Dec 31, 2025 | -1,880.00 |
| Sep 30, 2025 | -7,798.00 |
| Jun 30, 2025 | 36,856.00 |
| Mar 31, 2025 | -36,219.00 |
| Dec 31, 2024 | 1,928.00 |
| Sep 30, 2024 | 541.00 |
| Jun 30, 2024 | -697.00 |
| Mar 31, 2024 | -101.00 |
| Dec 31, 2023 | 2,219.00 |
| Sep 30, 2023 | 9,526.00 |
| Jun 30, 2023 | 9,625.00 |
| Mar 31, 2023 | -39,851.00 |
| Dec 31, 2022 | 31,871.00 |
| Sep 30, 2022 | -1,444.00 |
| Jun 30, 2022 | 36,768.00 |
| Mar 31, 2022 | -41,088.00 |
| Dec 31, 2021 | -4,098.00 |
| Sep 30, 2021 | 3,197.00 |
| Jun 30, 2021 | 5,644.00 |
| Mar 31, 2021 | 72,780.00 |
| Dec 31, 2020 | 3,189.00 |
| Sep 30, 2020 | -29,387.00 |
| Jun 30, 2020 | -44,740.00 |
| Mar 31, 2020 | 10,318.00 |
| Dec 31, 2019 | -10,789.00 |
| Sep 30, 2019 | 16,442.00 |
| Jun 30, 2019 | -20,389.00 |
| Mar 31, 2019 | 7,882.00 |
| Dec 31, 2018 | -6,957.00 |
| Sep 30, 2018 | 5,127.00 |
| Jun 30, 2018 | -9,387.00 |
| Mar 31, 2018 | -1,284.00 |
| Dec 31, 2017 | 6,198.00 |
| Sep 30, 2017 | 7,620.00 |
| Jun 30, 2017 | -69,464.00 |
| Dec 31, 2014 | -16.25 Mn |
| Sep 30, 2014 | -200,795.00 |
| Jun 30, 2014 | -75,930.00 |
| Mar 31, 2014 | 83,828.00 |
| Dec 31, 2013 | -65,422.00 |
| Sep 30, 2013 | -1,702.00 |
| Jun 30, 2013 | -24,042.00 |
| Mar 31, 2013 | -19,908.00 |
| Dec 31, 2012 | -4,989.00 |
| Sep 30, 2012 | -4,165.00 |
| Jun 30, 2012 | 1,182.00 |